Physician profile
Sunil Patel
NPI 1568844744
$5,768.96
in general payments reported to CMS, 2019-2025
13 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $13.45 · 2021: $132 · 2022: $2,464 · 2023: $59.82 · 2024: $2,694 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,875 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $740 · Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,875.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $740.00 |
| Food and Beverage | $390.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,035.37 | 2022-2024 | Da Vinci Surgical System |
| Urogen Pharma, INC. | $2,106.18 | 2022-2025 | |
| Photocure INC | $132.42 | 2021 | |
| Ferring Pharmaceuticals INC. | $95.08 | 2019 | |
| Ethicon US, LLC | $91.32 | 2022-2025 | Enseal X1 |
| Astellas Pharma US INC | $79.82 | 2022 | |
| Medtronic USA, INC. | $58.98 | 2019 | |
| Merck Sharp & Dohme LLC | $56.39 | 2025 | Keytruda, Welireg |
| Endo Pharmaceuticals INC. | $31.06 | 2022-2023 | Xiaflex |
| Tolmar, INC. | $27.88 | 2023 | |
| Progenics Pharmaceuticals, INC. | $24.16 | 2024 | |
| Provepharm INC. | $16.85 | 2025 | Bludigo |
| Glaxosmithkline, LLC. | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.